Read, Watch or Listen

Anne Wojcicki's nonprofit, TTAM Research Institute, will acquire the bankrupt genetic testing company 23andMe for $305 million, outbidding Regeneron Pharmaceuticals. The acquisition, which includes 23andMe's assets and customer data, follows 23andMe's Chapter 11 bankruptcy filing in March, marked by staff cuts and the resignation of its board. TTAM assures compliance with existing data privacy policies. The deal awaits court approval on June 17th. Concerns remain regarding data privacy, prompting a lawsuit from multiple states.

Prepared by Christopher Adams and reviewed by editorial team.